GLP-3 RT 50mg Peptides
Confidence starts with compounds you can trust, built for precision in every run.
GLP-3 RT is presented as a lyophilized peptide vial designed for laboratory workflows requiring reliable, consistent performance. This research peptide contains a total of 50mg per vial, offering a controlled format for protocol development, assay design, and method validation across a range of in vitro and ex vivo applications.
Ingredients: GLP-3 RT
- Each vial contains 50mg of GLP-3 RT, a research peptide commonly studied for receptor-mediated signaling and metabolic pathway exploration in controlled laboratory models.
The lyophilized format supports stability during storage and transport, enabling straightforward handling and precise aliquoting according to your lab’s SOPs. When incorporated into standard reconstitution and dilution protocols selected by your team, the material is suited to dose-ranging studies, assay optimization, and comparative analyses where consistency is critical. Each vial is lot-coded for traceability to help streamline documentation and quality review.
Engineered for dependable performance, this format is packaged to protect the peptide from moisture and light exposure during normal handling. Researchers value the predictable behavior of a well-characterized vial format, particularly when reproducibility, batch-to-batch continuity, and clean baselines are essential. Whether you are building a new method or maintaining a validated workflow, the 50mg presentation offers flexibility for multiple experimental runs without opening new materials mid-study.
Peptide Scientific Labs operates with a quality-first mindset. Every batch is produced in the United States and undergoes independent analytical testing to verify identity and assess purity, with results tied to each lot for transparent review. Materials are handled under controlled conditions, supported by documented procedures that prioritize consistency and compliance with research standards. GLP-3 RT is intended strictly for laboratory research use only and is not for human consumption, clinical use, or veterinary applications. Always follow appropriate PPE requirements and your institution’s safety guidelines when handling research peptides.
Choose a peptide source that aligns with rigorous scientific expectations—clear documentation, careful handling, and reliable composition—so your data reflect the integrity of your work from the first vial to the final result.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is GLP-3 RT?
GLP-3 RT is not a standard pharmacology name, and on research-vendor sites it is often used as shorthand for a retatrutide-style multi-incretin compound. Because that naming is vendor-dependent, the exact identity should be checked on the product page or certificate of analysis. It should therefore be described cautiously as a multi-pathway metabolic research compound.
What is GLP-3 RT typically studied for?
Compounds sold under this label are generally discussed for appetite, glucose regulation, energy expenditure, and multi-receptor incretin signaling. A careful FAQ should avoid presenting the shorthand as if it were a formal drug name and instead tell readers to verify the exact active ingredient before designing research around it.
What are GLP peptides?
GLP peptides — glucagon-like peptides — are a family of peptides derived from the post-translational processing of the proglucagon precursor. The main members are GLP-1 and GLP-2, both of which are produced primarily by intestinal L-cells. GLP-1 is studied in the context of insulin secretion, glucose metabolism, and appetite signaling, while GLP-2 is investigated for its role in intestinal epithelial biology.
A number of synthetic analogs and research compounds exist in this category, including semaglutide-class and tirzepatide-class sequences, as well as dual- and triple-agonist research peptides. All GLP peptide products from Peptide Scientific Labs are lyophilized research materials intended solely for in vitro laboratory investigation.
How do GLP analogs differ from native GLP hormones?
Native GLP-1 has a very short half-life in plasma — on the order of a few minutes — because it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4). GLP analogs are engineered peptides that modify the native sequence or attach additional groups such as fatty acid chains, in order to resist DPP-4 degradation, extend half-life, and optimize receptor binding.
This extended stability is what makes GLP analogs useful in research as practical tools for studying the GLP-1 and related receptor systems in controlled experiments. The analogs differ from native GLP hormones primarily in their pharmacokinetic profile and, in some cases, their receptor selectivity across the GLP-1, GIP, and glucagon receptor families.
What is the difference between GLP-1, GLP-2, and GLP-3 in research?
GLP-1 and GLP-2 are both produced from the proglucagon precursor. GLP-1 is studied in connection with the GLP-1 receptor, insulin secretion, and appetite signaling, while GLP-2 is studied primarily in connection with the GLP-2 receptor and intestinal epithelial biology. The two peptides share a common precursor but have different receptor targets and research focuses.
GLP-3 is not a classical endogenous peptide in the same way as GLP-1 and GLP-2. The term is sometimes used as a research label for engineered or triple-agonist peptides that combine activity at GLP-1, GIP, and glucagon receptors in a single molecule. In this sense, GLP-3 in research usually refers to a designed multi-target compound rather than a naturally occurring hormone.
This Product Contains
